These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 19333145)
1. Protease-activated receptor 2 blocking peptide counteracts endotoxin-induced inflammation and coagulation and ameliorates renal fibrin deposition in a rat model of acute renal failure. Jesmin S; Gando S; Zaedi S; Prodhan SH; Sawamura A; Miyauchi T; Hiroe M; Yamaguchi N Shock; 2009 Dec; 32(6):626-32. PubMed ID: 19333145 [TBL] [Abstract][Full Text] [Related]
2. Protease-activated receptor 2 blocking peptide counteracts endotoxin-induced inflammation and coagulation and ameliorates renal fibrin deposition in a rat model of acute renal failure. Spek CA; Brüggemann LW; Borensztajn KS Shock; 2010 Mar; 33(3):339; author reply 339-40. PubMed ID: 20160613 [No Abstract] [Full Text] [Related]
3. Chronological expression of PAR isoforms in acute liver injury and its amelioration by PAR2 blockade in a rat model of sepsis. Jesmin S; Gando S; Zaedi S; Sakuraya F Thromb Haemost; 2006 Dec; 96(6):830-8. PubMed ID: 17139380 [TBL] [Abstract][Full Text] [Related]
4. Effects of protease activated receptor (PAR)2 blocking peptide on endothelin-1 levels in kidney tissues in endotoxemic rat mode. Jesmin S; Shimojo N; Yamaguchi N; Mowa CN; Oki M; Zaedi S; Sultana SN; Rahman A; Islam M; Sawamura A; Gando S; Kawano S; Miyauchi T; Mizutani T Life Sci; 2014 May; 102(2):127-33. PubMed ID: 24641950 [TBL] [Abstract][Full Text] [Related]
5. The role of protease-activated receptors PAR-1 and PAR-2 in the repair of 16HBE 14o(-) epithelial cell monolayers in vitro. Ewen D; Clarke SL; Smith JR; Berger C; Salmon G; Trevethick M; Shute JK Clin Exp Allergy; 2010 Mar; 40(3):435-49. PubMed ID: 20210813 [TBL] [Abstract][Full Text] [Related]
9. Pathophysiology of disseminated intravascular coagulation (DIC) progresses at a different rate in tissue factor-induced and lipopolysaccharide-induced DIC models in rats. Asakura H; Suga Y; Yoshida T; Ontachi Y; Mizutani T; Kato M; Ito T; Morishita E; Yamazaki M; Miyamoto K; Nakao S Blood Coagul Fibrinolysis; 2003 Apr; 14(3):221-8. PubMed ID: 12695743 [TBL] [Abstract][Full Text] [Related]
10. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury. Idell S Crit Care Med; 2003 Apr; 31(4 Suppl):S213-20. PubMed ID: 12682443 [TBL] [Abstract][Full Text] [Related]
11. [Induction mechanism of shock: applying the etiology in judgment of the cause of death in forensic practice]. Tanaka N Nihon Hoigaku Zasshi; 2004 Sep; 58(2):130-40. PubMed ID: 15526767 [TBL] [Abstract][Full Text] [Related]
12. Immunoglobulin preparations attenuate organ dysfunction and hemostatic abnormality by suppressing the production of cytokines in lipopolysaccharide-induced disseminated intravascular coagulation in rats. Asakura H; Takahashi Y; Kubo A; Ontachi Y; Hayashi T; Omote M; Arahata M; Kadohira Y; Maekawa M; Yamazaki M; Morishita E; Takami A; Yoshida T; Miyamoto K; Nakao S Crit Care Med; 2006 Sep; 34(9):2421-5. PubMed ID: 16810104 [TBL] [Abstract][Full Text] [Related]
13. Decreased peroxisome proliferator-activated receptor alpha gene expression is associated with dyslipidemia in a rat model of chronic renal failure. Mori Y; Hirano T; Nagashima M; Shiraishi Y; Fukui T; Adachi M Metabolism; 2007 Dec; 56(12):1714-8. PubMed ID: 17998026 [TBL] [Abstract][Full Text] [Related]
14. Role of thrombin and its major cellular receptor, protease-activated receptor-1, in pulmonary fibrosis. Howell DC; Laurent GJ; Chambers RC Biochem Soc Trans; 2002 Apr; 30(2):211-6. PubMed ID: 12023853 [TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamics of active site-inhibited factor VIIa in endotoxin-induced coagulation in humans. Jilma B; Marsik C; Mayr F; Graninger MT; Taylor FB; Ribel MC; Erhardtsen E; Handler S; Eichler HG Clin Pharmacol Ther; 2002 Oct; 72(4):403-10. PubMed ID: 12386642 [TBL] [Abstract][Full Text] [Related]